Background: Neuroimaging studies help us better understand the pathophysiology and symptoms of Parkinson's disease (PD). In several of these studies, diffusion tensor imaging (DTI) was used to investigate structural changes in cerebral tissue. Although data have been provided as regards to specific brain areas, a whole brain meta-analysis is still missing.
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Literature search
To identify the articles for our literature review, we searched for publications on the Medline®/PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/), without any temporal restriction. To run our search, the keyword 'Parkinson' was associated with the following terms:
'diffusion tensor imaging', 'tractography', 'fractional anisotropy' and 'mean diffusivity'. After excluding duplicates (n=181) and inappropriate articles (n=177), we retained for analysis 39 relevant studies published between 2006 and 2016, reporting original research (editorials, letters to editors, discussions and reviews were excluded) with exploitable data (Fig. 1) . In total, data from 1855 individuals were considered in this review: 1087 PD patients and 768 healthy individuals. Among the 39 articles, we retained 38 studies for the FA analysis and 25 for the analysis of MD. We considered only the studies reporting the FA and/or the MD, since other indicators (such as axial and radial diffusivity) were less reported in the literature and that the number of data was insufficient to perform a meta-analysis. Tractography studies have not been included in our analysis: although tractography is increasingly being used to map fiber pathways relevant to PD (Pujol et al., 2017) , it is quite complicated in terms of methodology and its accuracy is still debated (Thomas et al., 2014) .
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Co-variables
For our analyses, we were also interested in participant demographic and clinical characteristics, if available, such as the gender and age of all individuals, as well as the disease duration of PD patients (Table 1A) . We did not consider the motor scores of the UPDRS -Unified Parkinson's Disease Rating 
Statistical analyses
Heterogeneity in a meta-analysis refers to the variation in outcomes between studies. The usual measure of heterogeneity is Cochran's Q, which is calculated as the weighted sum of squared differences between individual study effects and the pooled effect across studies. Cochran's Q test provides a p-value, with low p-values highlighting the presence of heterogeneity between studies without any size estimate. To improve the interpretation of our analyses, we also calculated the heterogeneity index (I²). This measure can be interpreted as the proportion of total variability explained by heterogeneity and refers to the percentage of variation across studies (Higgins, Thompson, Deeks, & Altman, 2003) . I² can be calculated from Q statistic (100% × [Q -degrees of freedom] / Q) and does not depend on the number of studies included in the meta-analysis. Thus, I² highlights the inconsistency across studies and ranges from 0% (i.e. no heterogeneity) to 100% (i.e.
the highest heterogeneity). Heterogeneity can be considered as low (0 < I² < 30%), moderate (30 < I² A C C E P T E D M A N U S C R I P T 9 < 60%), substantial (50 < I² < 90%) or considerable (75 < I² < 100% ).
Subset analysis of medication effects on SN
We performed a specific analysis on the effect of dopaminergic state on FA-D ES and MD-D ES for SN.
Some studies suggested that dopaminergic state can influence the results of functional (e.g., Tessitore et al., 2012; Krajcovicova et al., 2012) and anatomical (Salgado-Pineda, Delaveau, Falcon, & Blin, 2006 ) MRI acquisition. However, "the effects of medication on DTI are not known" (Prodoehl et al., 2013) . It is conceivable that medication states played a role and contributed to the results of the DTI analyses. To test this hypothesis on the data involved in our study, we ran an additional metaanalysis that considered only the SN, and that separated off-and on-medication data for FA-D ES and MD-D ES .
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Demographic and clinical characteristics
Demographic and clinical information available in the studies selected are summarized in Table 1A .
The gender distribution was highly heterogeneous for both PD patients (women proportion=0. 
MRI acquisition parameters
MRI acquisition parameters available in the studies selected are summarized in Table 1B . The parameters were highly variable, and some heterogeneity was observed for the voxel size (range: from 0.86x0.86x3 to 3.4x3.4x3 mm
for FA-D ES only, and no significant differences were found in the cerebellum. MD-D ES was highly heterogeneous in all significant clusters except in cortical areas (I 2 =34.5%).
At the anatomical level ( 
3):
The results in white matter was influenced by a gender effect (R=0.93; p=0.002), as well as the disease duration (R=-0.73; p=0.03).
MRI parameters were also highly correlated with D ES (Fig. 3) and moderate for FA in on-medication (30% < I 2 < 60%).
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4. Discussion
Summary of the findings
Our meta-analysis demonstrated that DTI was able to address structural differences between PD individuals and healthy controls, particularly in five cerebral regions sensitive to both FA and MD: the SN, the corpus callosum, the cingulate and temporal cortices, and the corticospinal tract. This latter Regarding the correlation results, FA-D ES was less dependent on co-variables than MD-D ES , consider the information about clinical and MRI parameters as potential limitations of our analyses in order to further interpret our findings.
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Pathophysiological and clinical implications of our findings
Subcortical nuclei
Changes in FA and/or MD in the SN due to PD is a controversial issue: no differences for both FA and MD, as well as an increase in FA, were reported (Menke, Jbabdi, Miller, Matthews, & Zarei, 2010; Wang et al., 2011) , while other studies reported decreases in FA in the SN (Chan et al., 2007; LingLing Chan et al., 2014; Du et al., 2011; Du et al., 2012; Jiang, Shi, Niu, Xie, & Yu, 2015; Peran et al., 2010; Prakash, Sitoh, Tan, & Au, 2012; Prodoehl et al., 2013; Rolheiser et al., 2011; Vaillancourt et al., 2009; Yoshikawa, Nakata, Yamada, & Nakagawa, 2004; Ota et al., 2013; Youn et al., 2015; Zhan et al., 2012; G. Zhang et al., 2015) and/or increases in MD (Du et al., 2014; Koji Kamagata et al., 2016; Loane et al., 2016; Nagae et al., 2016; Scherfler et al., 2013; Schwarz et al., 2013) . Moreover, correlations between PD severity and FA were found both significant (Chan et al., 2007; Zhan et al., 2012) and not significant (Du et al., 2011) . It has also been shown that FA would be able to distinguish healthy subjects from de novo PD individuals, especially in the caudal region of the SN (Vaillancourt et al., 2009 ). Thus, DTI in the SN should help to distinguish PD patients from healthy controls, and possibly to detect individuals susceptible to developing PD: in fact, FA was found sensitive enough to distinguish healthy controls from controls who have been exposed to chemicals for about 20 years, and identified as a population at risk of developing PD (Du et al., 2014) . Our
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results do not allow concluding to a possible ability of DTI to track PD progression. Nevertheless, previous studies reported that DTI (with FA, MD, radial and axial diffusivity) is able to track progression of the SN longitudinally in PD (Loane et al., 2016; Ofori et al., 2015; Yu Zhang et al., 2016) . Moreover, the DTI changes in SN seem to be linked with bradykinesia, cognitive status (Ofori et al., 2015) and dopaminergic deficit (Yu Zhang et al., 2016) . First, the patient movement depending on the dopaminergic state during scanning (e.g., tremor when "off" or dyskinesia when "on") could be an argument in favour of image acquisition deterioration. It is also conceivable that medication states induced a neuroimaging artefact in the form of an increase in grey matter volume in the midbrain (substantia nigra, tegmental ventral area and subthalamic nucleus) previously reported with VBM (Salgado-Pineda et al., 2006), but not with DTI (Chung et al., 2017) . In fact, levodopa could have intrinsic magnetic properties that could induce a variation in signal intensity and lead to a misclassification of voxels as part of grey or white matter. The interaction of dopaminergic treatments with iron (chelation or binding) could also partly explain this effect (Campbell & Hasinoff, 1991) . Previous meta-analyses did not take this effect into account (Cochrane & Ebmeier, 2013; Schwarz et al., 2013) , and future studies should pay attention to medication states, particularly for the investigation in the SN, as a precaution principle.
Regarding the putamen and the pallidum, our analysis showed a significant increase in MD-D ES , as already demonstrated (Menke et al., 2014; Nagae et al., 2016) and supporting the idea of a degeneration of the pallidum in PD patients compared with controls (Rajput, Voll, Rajput, Robinson, & Rajput, 2009 ). This result is still a matter of debate since previous DTI studies also failed to detect such differences in the putamen (Gattellaro et al., 2009; Peran et al., 2010; Loane et al., 2016 ; Nagae et al., 2016) and the pallidum (Gattellaro et al., 2009) , even suggesting that the pallidum can be spared in PD (Gattellaro et al., 2009) . DTI of the putamen and pallidum does not seem particularly discriminating and using other DTI indexes (e.g., orientation dispersion index, longitudinal diffusivity)
could be helpful to provide significant differences in these subcortical regions (Koji Kamagata et al., 2016; Prodoehl et al., 2013) .
The caudate nucleus was associated with significantly increased FA-D ES for PD patients compared with healthy controls, but with no change in MD-D ES (Gattellaro et al., 2009; Jiang et al., 2015; Loane et al., 2016; Nagae et al., 2016; Prodoehl et al., 2013) . This increase would reveal a selective neurodegeneration, reflecting much likely some gliosis (Budde, Janes, Gold, Turtzo, & Frank, 2011) as already reported in Parkinsonian syndromes (Planetta et al., 2016) . One can also imagine an alternative interpretation that would lead to consider a potential compensatory reorganization previously reported using functional connectivity (Hou et al., 2016) . However, some studies also reported degeneration of the caudate nucleus using VBM (Reetz et al., 2009; Watanabe et al., 2013; Zhang et al., 2014; Ellfolk et al., 2013; Herman, Rosenberg-Katz, Jacob, Giladi, & Hausdorff, 2014; Kostic et al., 2012; O'Callaghan, Shine, Lewis, & Hornberger, 2014) or DTI (e.g., Menke et al., 2009 , Wang et al., 2011 Rossi, Ruottinen, Saunamäki, Elovaara, and Dastidar, 2014) . These latter studies
were not included in our meta-analysis, since they did not fulfil the inclusion criteria: DTI investigation of the caudate nucleus requires further studies in order to draw robust conclusions on this point. Post-mortem observations could be an option to objectify possible reorganization of this nucleus.
Cortical areas
In general, our meta-analysis showed that the D ES in cortical regions were highly heterogeneous for FA. More specifically, the D ES of the temporal and cingulate cortices displayed a significant increase in MD and a significant decrease in FA. While PD patients without cognitive decline present no FA changes in temporal regions when compared with healthy controls (Price et al., 2016) , temporal cortex degeneration has been associated with cognitive status decline (Deng et al., 2013; Carlesimo et al., 2012) . Using a classification analysis, superior temporal regions have been shown to be discriminant between healthy controls and PD (Ota et al., 2013) . Similarly, cingulate cortex changes were correlated to cognitive performance (Kamagata et al., 2012; Zheng et al., 2014) and can help to discriminate PD patients with dementia from healthy controls (Deng et al., 2013; Matsui et al., 2007) .
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All these findings taken together suggest that the cognitive status of PD patients is principally associated with perceptible damage in the temporal and cingulate cortices.
For the olfactory cortex, our meta-analysis showed a significant increase in MD in individuals with PD compared with healthy controls. In accordance with the Braak model of temporal degeneration in PD, considering the olfactory cortex as an early degenerative structure (C. H. Hawkes, Del Tredici, & Braak, 2007) , two studies included in our analysis aimed at testing the possibility of the structural changes in the olfactory tract identified by DTI as a biomarker for PD diagnosis (Rolheiser et al., 2011; Scherfler et al., 2013) . In fact, they reported FA and MD changes between PD patients and healthy controls, and a correlation between olfactory performance test and motor scores (Rolheiser et al., 2011; Scherfler et al., 2013) . However, these studies did not involve any de novo PD patients.
Another study, using DTI and statistical modelling, recently suggested that olfactory regions were particularly efficient at distinguishing de novo drug-naïve PD patients from healthy controls (Nigro et al., 2016) . It is too early to conclude about the sensitivity and specificity of DTI in olfactory regions as a biomarker of PD, but the results of our meta-analysis suggest that it could be used by clinicians as an additional measure.
White matter
MD-D ES in white matter was highly correlated with demographic and clinical data, as well as with MRI parameters. Our analyses displayed significant changes in FA-D ES (decrease) and MD-D ES (increase) in
the corpus callosum. It has been shown that the deterioration of the corpus callosum genu is linked to PD dementia (Kamagata, Motoi, et al., 2013b), as well as executive and attention dysfunctions (Zheng et al., 2014) . DTI of the corpus callosum (in the body and the splenium) can help differentiating PD patients according to their cognitive status (normal, mild cognitive impairment, or dementia; Deng et al., 2013); for this purpose, MD demonstrated to be more accurate than FA (Wiltshire et al., 2010) . In addition, structural alteration of the corpus callosum, shown using DTI, seems to be involved in predominant gait disorders (Ling-Ling Chan et al., 2014) and impulse control ACCEPTED MANUSCRIPT
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17 disorders (Yoo et al., 2015) . Other studies did not observe any change in FA and MD, and did not report any correlations with clinical assessments (Boelmans et al., 2010; Ito, Makino, Shirai, & Hattori, 2008) . The corpus callosum is probably injured in PD, possibly in advanced stages of PD (C. H.
Hawkes et al., 2007).
We also observed a significant FA-D ES increase and a MD-D ES decrease in the corticospinal tract, suggesting a reorganization of these fibers that can be interpreted as either a compensatory mechanism as a "response to [the] decreased input from the thalamus and striatum", or a selective neurodegeneration where increase of FA should be the "consequence of altered pallido-thalamic activity" (Mole et al., 2016) . The increase in FA possibly reflects an increase in axonal density in some pathways, as the result of axonal sprouting (Arkadir, Bergman, & Fahn, 2014) . This is in line with other previous studies using DTI (Gattellaro et al., 2009; Kamagata et al., 2012 ; Deng et al., 2013; Nilsson et al., 2007) . Regarding the internal and external capsules, a significant increase in MD-D ES was barely observed in our analysis, as previously observed (Zhan et al., 2012) . A correlation between the increase in MD in the internal capsule and the increase in the UPDRS motor score (Vercruysse et al., 2015) , as well as between FA, MD and gait difficulty (Lenfeldt, Holmlund, Larsson, Birgander, & Forsgren, 2016), was also reported. Altogether, these findings suggest that degenerations of the internal and external capsules are possible additional markers of PD.
Methodological considerations
Several limitations of our meta-analysis have to be acknowledged, mainly based on the characteristics of the anatomical structures and the technical DTI acquisition parameters.
Consequently, and more specifically, the correlations we found should be interpreted with caution.
To a certain extent, they suggested some sensitivity of FA and MD (in several territories) to other factors, such as demographics, clinical data and MRI parameters. But it is difficult to draw any robust conclusion regarding causality relationships between factors. Nevertheless, these factors should be considered in future research in order to control as much as possible influences on DTI acquisition. human cortex" (Mori & Zhang, 2006) .
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From a technical perspective
Many studies aimed at determining the best criteria to limit artefacts in DTI acquisition (Gallichan et al., 2010 , and Viallon et al., (2015) considered that a high spatial resolution should be fixed at 1 mm 3 (particularly for crossing-fiber regions; Oouchi et al., 2007) . Moreover, it is recommended to use a 3 Tesla MRI to reduce the noise (for all tissues), despite a possible increase in spatial distortions (Alexander, Lee, Wu, & Field, 2006) . Jones, Knösche, & Turner, (2013) recommended to use at least 30 diffusion directions, in order "to obtain robust estimates of tensorderived properties"; Ni et al. (2006) only observed differences of FA between 6, 21 and 31 directions for regions with low anisotropy (Ni, Kavcic, Zhu, Ekholm, & Zhong, 2006) . As much as possible, the use of parallel image acquisitions (for example, with generalized auto-calibrating partially parallel acquisition; Griswold et al., 2002) seems to be recommended. Moreover, the software algorithms used to calculate DTI parameters could introduce variability, but each software presents its own strengths and weaknesses (Liu, Zhu, & Zhong, 2015) . It is also possible to use other MR acquisition schemes, for example diffusion spectrum imaging, to enhance DTI acquisition. This method, with longer acquisition duration than DTI (from 15 to 60 minutes), makes it possible to measure fiber crossing (Hagmann et al., 2006) . Studies using VBM are quite numerous, and very informative as
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well; in order to ensure an exhaustive and non-invasive study of pathophysiology of PD, combining DTI and VBM analyses represents a very good option that should be considered when studying PD cortical degeneration.
Conclusion
Our meta-analysis aimed at providing a quantitative evaluation of structural brain changes associated with PD. We showed that DTI is particularly relevant for subcortical areas (lesions in the SN, the putamen and the pallidum, and a possible reorganization or a selective neurodegeneration in the caudate nucleus). It is also informative for cortical areas and white matter. DTI evaluation of structural lesions remains difficult, due to the variability in PD pathophysiology and MRI acquisition parameters (e.g. artefacts and nature of the region of interest). However, our meta-analysis and literature review contributes to significantly increasing our knowledge of PD pathophysiology. It also addresses the interesting possibility of follow-up of the disease severity and associated brain structural modulations using in vivo imaging. From our review and meta-analysis, we can summarize the following points: DTI in olfactory regions could participate to the diagnosis of PD; FA and MD in SN are good indicators to identify PD patients, but also for PD progression; The corpus callosum degenerates in PD, but with a high variability; its integrity is correlated to specific symptoms (e.g., 
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A C C E P T E D M A N U S C R I P T Regions that have a significant effect size for FA or MD are highlighted in bold.
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Highlights:
 Meta-analyses on DTI in Parkinson's disease are scarce  DTI is as a sensitive method to study PD pathophysiology and progression  DTI in olfactory regions could participate to the diagnosis of PD  DTI in the substantia nigra are good indicator to identify PD patients, but also for PD progression  Further studies are required to conclude about the changes in caudate and the corticospinal tract
